Product Code: RP-ID-10086184 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10086184
Market Overview:
Global Vascular Stent Market: Analysis By Type (Coronary, Peripheral), Technology (Bare Metal, Drug Eluting, Bio-Resorbable), Mode of Delivery, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Mode of delivery (Self Expandable, Drug Eluting Expandable), By End User (Hospital, Ambulatory Surgical Centre), By Region (North America, Europe, Asia Pacific, ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil)
" In 2021, the global vascular stent market value is estimated to reach ~USD 10 billion. A vascular stent is a small device used to remove and prevent blockages in heart valves and arteries. It is also used to provide internal structural support for narrow or occluded blood vessels. The process of placing a stent in the body is called stent placement. Vascular stents are usually made of non-absorbable materials such as polyethylene, polypropylene or stainless steel or cobalt-chromium alloys. They can range from tubular stent grafts used to repair aneurysms to expandable metal meshes used in percutaneous vascular interventions. Once the stent is placed in the desired position, it is expanded using a balloon or self-expanding mechanism.
The rapid growth of the elderly population is one of the main factors driving the growth of the global market. In addition, the incidence of various diseases such as peripheral artery disease (PAD), aortic aneurysm and ischemic heart disease has also increased. The frequent occurrence of these conditions has led to an increasing demand for vascular stents.
This can be attributed to lifestyle choices such as smoking and heavy drinking, as well as people's lack of physical activity and unhealthy eating habits. In addition, consumers; increasing propensity for minimally invasive (MI) procedures is also driving market growth. MI vascular stent surgery can ensure shorter hospital stays, faster recovery and greater comfort for patients.
In addition, the emerging trend of endovascular and peripheral aneurysm repair stent graft (EVAR) has also promoted the growth of the market. EVAR is widely used in elderly patients with renal insufficiency, while peripheral stent implantation is used to support the femoral popliteal artery and subpopliteal artery above the knee. Looking ahead, Kenneth Research predicts that the global vascular stent market will grow at a compound annual growth rate of ~7% during the period 2022-2030.
REPORT COVERAGE :
Historical, current and future market trends by product type market segmentation: coronary stent peripheral vascular stent Evar stent graft market segmentation by material market segmentation: metal stent cobalt-chromium-platinum-chromium-nickel-titanium stainless steel Other markets by delivery method Segmentation: Inflatable balloon stent self-expandable stent market segmentation by end user: hospitals and heart centers, outpatient surgery centers.
COMPETITION LANDSCAPE :
The report also analyzes the market competition landscape of some major players, such as Medtronic, Abbott Laboratories, Boston Scientific, Biotronik Se & Co. Kg, Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Sciences Life Pvt. Ltd., Vascular Concepts Limited, CR Bard, Inc., WL Gore and Associates, Inc., Endologix, Inc., Lombard Medical, Translumina Gmbh, Jotec Gmbh, etc."
Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Medtronic, Terumo Corporation, B. Braun Melsungen, W.L. Gore & Associates, Cook Medical, Biotronik, Meril LifeSciences.
Related Reports
Proof of Quality & Reliability
